Hlthcare Company Profile
✉ Email this page to a colleague
What is the competitive landscape for HLTHCARE, and what generic and branded alternatives to HLTHCARE drugs are available?
HLTHCARE has four approved drugs.
Summary for Hlthcare
| US Patents: | 0 |
| Tradenames: | 4 |
| Ingredients: | 4 |
| NDAs: | 4 |
Drugs and US Patents for Hlthcare
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hlthcare | ATENOLOL | atenolol | TABLET;ORAL | 073026-001 | Sep 17, 1991 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Hlthcare | DROSPIRENONE AND ETHINYL ESTRADIOL | drospirenone; ethinyl estradiol | TABLET;ORAL | 203291-001 | Jul 18, 2017 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Hlthcare | DOXORUBICIN HYDROCHLORIDE | doxorubicin hydrochloride | INJECTABLE;INJECTION | 200146-001 | Jul 18, 2012 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
| Hlthcare | METHOCARBAMOL | methocarbamol | TABLET;ORAL | 203550-002 | Feb 8, 2017 | AA | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Hlthcare | ATENOLOL | atenolol | TABLET;ORAL | 073026-003 | Sep 17, 1991 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Hlthcare | METHOCARBAMOL | methocarbamol | TABLET;ORAL | 203550-001 | Feb 8, 2017 | AA | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Hlthcare | ATENOLOL | atenolol | TABLET;ORAL | 073026-002 | May 1, 1992 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
